| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $636.6M | $709.3M | $888.4M |
| YoY Revenue Growth % | -10.2% | -20.2% | — |
| Gross Profit | $135.1M | $159.6M | — |
| Gross Margin % | 21.2% | 22.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$30.3M | -$15.5M | $56.9M |
| Operating Margin % | -4.8% | -2.2% | 6.4% |
| Net Income (GAAP) | -$77.1M | -$53.0M | $19.2M |
| EBITDA (Normalized) | $9.0M | $36.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $7.5M | $54.2M | $115.6M |
| Capital Expenditures (CapEx) | $49.1M | $65.1M | — |
| Free Cash Flow (FCF) | -$41.6M | -$10.9M | $115.6M |
| FCF Margin % | -6.5% | -1.5% | 13.0% |
| Return on Invested Capital (ROIC %) | -13.8% | -6.7% | — |
| Cash & Short-Term Equivalents | $5.7M | $91.6M | — |
| Total Debt (Short + Long Term) | $253.9M | $285.1M | — |
| Total Stockholders' Equity | -$74.2M | -$10.5M | — |